Drug interactions
Glimepiride + Metformin-sitagliptin
Severity: Moderate
Glimepiride and Metformin-sitagliptin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Adding a DPP-4 inhibitor to a sulfonylurea increases the risk of hypoglycemia, since the sulfonylurea drives insulin release regardless of glucose level. Metformin contributes additional glucose lowering.
What this interaction means in plain words
Glimepiride and Metformin-sitagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Glimepiride belongs to Endocrine; Metformin-sitagliptin belongs to Endocrine.
Why it happens
Additive glucose-lowering pharmacodynamic effects, with glucose-dependent incretin enhancement layered on sulfonylurea-driven insulin secretion.
What to do
Consider reducing the glimepiride dose when starting sitagliptin-metformin and educate patients on recognizing and treating hypoglycemia.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride and Metformin-sitagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-sitagliptin
Other interactions of Glimepiride
Frequently asked questions
Can I take Glimepiride with Metformin-sitagliptin?
MediHelp rates the interaction as moderate. Glimepiride and Metformin-sitagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Adding a DPP-4 inhibitor to a sulfonylurea increases the risk of hypoglycemia, since the sulfonylurea drives insulin release regardless of glucose level. Metformin contributes additional glucose lowering.
How serious is the interaction between Glimepiride and Metformin-sitagliptin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing the glimepiride dose when starting sitagliptin-metformin and educate patients on recognizing and treating hypoglycemia.
What other medicines interact with Metformin-sitagliptin?
MediHelp also lists interactions of Metformin-sitagliptin with, for example, Clozapine, Contrast media, Diatrizoate meglumine / diatrizoate. The full list is on the Metformin-sitagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
